New research indicates that drugs called dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients. The research presented was at the American College of Rheumatology Annual Meeting in San Diego. Dipeptidyl peptidase-4 inhibitors (commonly called DPP-4 inhibitors) such as linagliptin (TradjentaA (Regd) ), saxagliptin (OnglzaA (Regd) ), and sitagliptin (JanuviaA (Regd) ) ...You have just read an article categorized health
titled Diabetes Medication May Also Reduce the Risk of Autoimmune Diseases.
Written by:
editor - Monday, October 28, 2013
There are currently no comments for "Diabetes Medication May Also Reduce the Risk of Autoimmune Diseases"
Post a Comment